EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director GUYER DAVID R unloaded Company’s shares for reported $0.12 million on Jun 03 ’24. In the deal valued at $10.30 per share,11,625 shares were sold. As a result of this transaction, GUYER DAVID R now holds 3,700 shares worth roughly $34706.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, GUYER DAVID R sold 11,625 shares, generating $147,045 in total proceeds. Upon selling the shares at $12.65, the Director now owns 5,550 shares.
Before that, Cormorant Asset Management, LP bought 850,000 shares. EyePoint Pharmaceuticals Inc shares valued at $10,081,721 were divested by the 10% Owner at a price of $11.86 per share. As a result of the transaction, Cormorant Asset Management, LP now holds 8,325,000 shares, worth roughly $78.09 million.
JP Morgan initiated its EyePoint Pharmaceuticals Inc [EYPT] rating to an Overweight in a research note published on January 22, 2024; the price target was $35. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in early November with a ‘”a Buy”‘ rating. Robert W. Baird began covering EYPT with “an Outperform” recommendation on April 21, 2023. Chardan Capital Markets started covering the stock on July 07, 2022. It rated EYPT as “a Buy”.
Price Performance Review of EYPT
On Friday, EyePoint Pharmaceuticals Inc [NASDAQ:EYPT] saw its stock jump 0.97% to $9.38. Over the last five days, the stock has gained 3.08%. EyePoint Pharmaceuticals Inc shares have fallen nearly -59.41% since the year began. Nevertheless, the stocks have risen 33.43% over the past one year. While a 52-week high of $30.99 was reached on 02/08/24, a 52-week low of $5.67 was recorded on 06/11/24. SMA at 50 days reached $14.44, while 200 days put it at $16.14. A total of 0.52 million shares were traded, compared to the trading of 0.77 million shares in the previous session.
Levels Of Support And Resistance For EYPT Stock
The 24-hour chart illustrates a support level at 9.16, which if violated will result in even more drops to 8.94. On the upside, there is a resistance level at 9.55. A further resistance level may holdings at 9.72. The Relative Strength Index (RSI) on the 14-day chart is 31.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.15%. Stochastics %K at 21.40% indicates the stock is a holding.
The most recent change occurred on March 01, 2021 when Cowen began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
